FDA warning letter
Issue date
7 Dec 2022
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
13 Dec 2022
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Centrient Pharmaceuticals
Distributor
Audited
Audit report available
Warning letter
Headquarters
NetherlandsSites
Spain
India
People's Republic of China